Press Releases

Earlens Corporation, a medical technology company that has created the world's first nonsurgical hearing solution that directly vibrates the eardrum, announced today that they have entered into a strategic agreement with Verily, an Alphabet company, to develop next-generation capabilities for the Earlens® Contact Hearing Solution. According to the Hearing Loss Association of America, about 20 percent of Americans, or 48 million people, report some degree of hearing loss. Yet

PENTAX Medical, a healthcare industry leader in endoscopic diagnosis and therapy, today announced that it has received US FDA 510(k) clearance for its IMAGINA Endoscopy System, an innovative endoscopy platform for gastrointestinal (GI) procedures at Ambulatory Surgery Centers (ASCs). IMAGINA offers practitioners a modern user interface and unique endoscope design to provide excellent visualization, improve the operator experience and positively influence long-term patient care costs.

OrthoGrid Systems, Inc., a global medtech leader in the development, innovation, and commercialization of alignment technologies and platforms for orthopedic surgery, is partnering with University of Utah Health, a leading academic health care system, to provide orthopaedic surgeons with the latest technology in surgical precision to reduce hospital readmissions and improve patient outcomes. University of Utah Health is the Mountain West's only academic health care system, combi

Cloudbreak Health, LLC., a leading unified telemedicine and video medical interpretation solutions provider, officially launched its most advanced product offering to date, MarttiNext. The solution brings significant enhancement to the user experience with rock-solid network stability that enhances accessibility, scalability and reliability. “Hundreds of our large health system customers have made the transition to MarttiNext in 2019 and now, it’s time to expand this bre

Biolog-id LLC, a world leader in connected solutions for blood and other high value health products, announced today that LiveServe Blood Center, the leading provider of blood products in Iowa, Nebraska, and South Dakota, will implement Biolog-id’s cutting-edge technology solution in its blood supply chain. The technology solution provides real-time visibility into blood product location and movement, providing actionable data to streamline inventory and improve efficiencies to maximize

SCI Solutions (SCI), the industry’s most widely adopted EHR-agnostic online care coordination marketplace, today announced it has acquired Tonic Health, a broadly deployed SaaS-based digital self-service technology platform widely used by patients to complete intake forms, check-in for appointments, self-report outcome measures and make payments. The combination of SCI’s market-leading digital engagement platform, including patient scheduling, referral management, revenue cycle wo

MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.   The FRED® device is the first flow diverter in the U.S. to use a self-expanding braided nitinol mesh to help re-direct blood flow and promote aneurysm occlusion. The unique interwoven nitinol design of the FRED® device allows for smooth d

KDx Diagnostics, Inc., announced today that the Food and Drug Administration (FDA) has granted "Breakthrough Device" designation for its URO17™ Bladder Cancer Recurrence Test. This revolutionary new test exploits a novel cancer marker that could dramatically improve the accuracy and sensitivity of non-invasive bladder cancer testing. Bladder cancer is the 6th most common cancer in the US, and 81,000 people are newly diagnosed with the disease annually. Moreover, blad

Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease, has been designated for the Breakthrough Devices Program by the U.S. Food and Drug Administration (FDA). The Breakthrough Devices Program is designed to give patients and health care providers timely access to medical devices that provide for more effective treatment or diagnosis of life-threatening or irrev

Change Healthcare unveiled its API & Services Connection™, a marketplace for open, standards-based application programming interface (API) products. Now, any healthcare organization––payers, providers, vendors, consultants, and independent developers––can leverage the same capabilities ....